131 related articles for article (PubMed ID: 9073469)
1. Inflammatory response of mouse skin exposed to the very potent carcinogen dibenzo[a,l]pyrene: a model for tumor promotion.
Casale GP; Higginbotham S; Johansson SL; Rogan EG; Cavalieri EL
Fundam Appl Toxicol; 1997 Mar; 36(1):71-8. PubMed ID: 9073469
[TBL] [Abstract][Full Text] [Related]
2. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland.
Cavalieri EL; Higginbotham S; RamaKrishna NV; Devanesan PD; Todorovic R; Rogan EG; Salmasi S
Carcinogenesis; 1991 Oct; 12(10):1939-44. PubMed ID: 1934274
[TBL] [Abstract][Full Text] [Related]
3. Profiles of cytokine mRNAs in the skin and lymph nodes of SENCAR mice treated epicutaneously with dibenzo[a,l]pyrene or dimethylbenz[a]anthracene reveal a direct correlation between carcinogen-induced contact hypersensitivity and epidermal hyperplasia.
Casale GP; Cheng Z; Liu Jn; Cavalieri EL; Singhal M
Mol Carcinog; 2000 Feb; 27(2):125-40. PubMed ID: 10657905
[TBL] [Abstract][Full Text] [Related]
4. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin.
Higginbotham S; RamaKrishna NV; Johansson SL; Rogan EG; Cavalieri EL
Carcinogenesis; 1993 May; 14(5):875-8. PubMed ID: 8504480
[TBL] [Abstract][Full Text] [Related]
5. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
[TBL] [Abstract][Full Text] [Related]
6. Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol.
Platt KL; Dienes HP; Tommasone M; Luch A
Chem Biol Interact; 2004 Jun; 148(1-2):27-36. PubMed ID: 15223354
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
[TBL] [Abstract][Full Text] [Related]
8. Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene.
Amin S; Desai D; Dai W; Harvey RG; Hecht SS
Carcinogenesis; 1995 Nov; 16(11):2813-7. PubMed ID: 7586203
[TBL] [Abstract][Full Text] [Related]
9. Reduction of tumorigenicity and of dihydrodiol formation by fluorine substitution in the angular rings of dibenzo(a,i)pyrene.
Hecht SS; LaVoie EJ; Bedenko V; Pingaro L; Katayama S; Hoffmann D; Sardella DJ; Boger E; Lehr RE
Cancer Res; 1981 Nov; 41(11 Pt 1):4341-5. PubMed ID: 7306963
[TBL] [Abstract][Full Text] [Related]
10. Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P) or its metabolites and in rat mammary gland treated with DB[a,l]P.
Cavalieri EL; Rogan EG; Li KM; Todorovic R; Ariese F; Jankowiak R; Grubor N; Small GJ
Chem Res Toxicol; 2005 Jun; 18(6):976-83. PubMed ID: 15962932
[TBL] [Abstract][Full Text] [Related]
11. Evidence that error-prone DNA repair converts dibenzo[a,l]pyrene-induced depurinating lesions into mutations: formation, clonal proliferation and regression of initiated cells carrying H-ras oncogene mutations in early preneoplasia.
Chakravarti D; Mailander PC; Cavalieri EL; Rogan EG
Mutat Res; 2000 Nov; 456(1-2):17-32. PubMed ID: 11087892
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Nelson G; Ross JA; Allison J; Adams L; King LC
Carcinogenesis; 1997 Oct; 18(10):1973-8. PubMed ID: 9364008
[TBL] [Abstract][Full Text] [Related]
13. Tumor-initiating activity in mouse skin and carcinogenicity in rat mammary gland of dibenzo[a]pyrenes: the very potent environmental carcinogen dibenzo[a, l]pyrene.
Cavalieri EL; Rogan EG; Higginbotham S; Cremonesi P; Salmasi S
J Cancer Res Clin Oncol; 1989; 115(1):67-72. PubMed ID: 2921274
[TBL] [Abstract][Full Text] [Related]
14. Epidermal hyperplasia after topical application of benzo (a) pyrene, benzo (a) pyrene diol epoxides, and other metabolites.
Bresnick E; McDonald TF; Yagi H; Jerina DM; Levin W; Wood AW; Conney AH
Cancer Res; 1977 Apr; 37(4):984-90. PubMed ID: 844052
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and tumor-initiating activity in mouse skin of dibenzo[a,l]pyrene syn- and anti-fjord-region diolepoxides.
Gill HS; Kole PL; Wiley JC; Li KM; Higginbotham S; Rogan EG; Cavalieri EL
Carcinogenesis; 1994 Nov; 15(11):2455-60. PubMed ID: 7955091
[TBL] [Abstract][Full Text] [Related]
16. The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin.
Chakravarti D; Venugopal D; Mailander PC; Meza JL; Higginbotham S; Cavalieri EL; Rogan EG
Mutat Res; 2008 Jan; 649(1-2):161-78. PubMed ID: 17931959
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and mutagenicity of the diastereomeric fjord-region 11,12-dihydrodiol 13,14-epoxides of dibenzo[a,l]pyrene.
Luch A; Glatt H; Platt KL; Oesch F; Seidel A
Carcinogenesis; 1994 Nov; 15(11):2507-16. PubMed ID: 7955100
[TBL] [Abstract][Full Text] [Related]
18. Tumor-initiating activity of the (+)-(S,S)- and (-)-(R,R)- enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene in mouse skin.
Luch A; Friesel H; Seidel A; Platt KL
Cancer Lett; 1999 Mar; 136(2):119-28. PubMed ID: 10355740
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay.
Ralston SL; Coffing SL; Seidel A; Luch A; Platt KL; Baird WM
Chem Res Toxicol; 1997 Jun; 10(6):687-93. PubMed ID: 9208176
[TBL] [Abstract][Full Text] [Related]
20. Dibenzo[A,L]pyrene-induced genotoxic and carcinogenic responses are dramatically suppressed in aryl hydrocarbon receptor-deficient mice.
Nakatsuru Y; Wakabayashi K; Fujii-Kuriyama Y; Ishikawa T; Kusama K; Ide F
Int J Cancer; 2004 Nov; 112(2):179-83. PubMed ID: 15352028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
